Fezolinetant

From WikiMD's Wellnesspedia

What is Fezolinetant?[edit | edit source]

  • Fezolinetant (Veozah), is a small-molecule NK3 receptor antagonist.
Fezolinetant

What are the uses of this medicine?[edit | edit source]

  • Fezolinetant (Veozah) is a prescription medicine used to reduce moderate to severe vasomotor symptoms due to menopause.
  • Veozah is not a hormone.
  • Vasomotor symptoms are the feelings of warmth in the face, neck, and chest, or sudden intense feelings of heat and sweating (“hot flashes” or “hot flushes”).

How does this medicine work?[edit | edit source]

  • Veozah is a neurokinin 3 (NK3) receptor antagonist that blocks neurokinin B (NKB) binding on the kisspeptin/neurokinin B/dynorphin (KNDy) neuron to modulate neuronal activity in the thermoregulatory center.
  • Fezolinetant has high affinity for the NK3 receptor, which is more than 450-fold higher than binding affinity to NK1 or NK2 receptors.

Who Should Not Use this medicine ?[edit | edit source]

This medicine cannot be used in patients who:

  • have cirrhosis.
  • have severe kidney problems or kidney failure.
  • are taking certain medicines called CYP1A2 inhibitors.

What drug interactions can this medicine cause?[edit | edit source]

  • Tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take while taking Veozah.
  • Veozah may affect the way other medicines work, and other medicines may affect how Veozah works. Keep a list of your medicines and show it to your healthcare provider and pharmacist when you get a new medicine.

Be sure to mention any of the following:

  • CYP1A2 Inhibitors
  • Veozah is contraindicated in individuals using CYP1A2 inhibitors.

Is this medicine FDA approved?[edit | edit source]

  • Fezolinetant was approved for medical use in the United States in May 2023.
  • Fezolinetant is the first neurokinin 3 (NK3) receptor antagonist approved by the US Food and Drug Administration (FDA) to treat moderate to severe hot flashes from menopause.

How should this medicine be used?[edit | edit source]

Recommended dosage:

  • Take a single 45 mg Veozah tablet orally once daily with or without food.

Administration:

  • Take 1 Veozah tablet by mouth with or without food at about the same time each day.
  • Swallow the Veozah tablet whole with liquid.
  • Do not cut, crush, or chew the tablet.
  • If you miss a dose of Veozah, take the missed dose as soon as possible on the same day, with at least 12 hours before the next scheduled dose.
  • Return to your normal schedule the following day.

What are the dosage forms and brand names of this medicine?[edit | edit source]

This medicine is available in fallowing doasage form:

  • As Tablets: 45 mg

This medicine is available in fallowing brand namesː

  • Veozah

What side effects can this medication cause?[edit | edit source]

The most common side effects of this medicine include:

Less common, but serious side effects may include:

  • increased liver blood test values

What special precautions should I follow?[edit | edit source]

  • Elevations in serum transaminase concentrations greater than three times the upper limit of normal (ULN) occurred in the clinical trials. Perform bloodwork prior to initiation of Veozah to evaluate for hepatic function and injury. Do not start therapy if serum transaminase concentration is equal to or exceeds two times the ULN. Perform follow-up evaluations of hepatic transaminase concentration at 3 months, 6 months, and 9 months after initiation of therapy.
  • Inform patients that they will have to have a blood test to evaluate their liver before beginning Veozah and while using Veozah at 3 months, 6 months, and 9 months of use, and when clinically indicated to evaluate symptoms of liver abnormalities such as nausea, vomiting, or yellowing of the skin or eyes.
  • Inform patients of possible serious adverse reactions of Veozah including hepatic transaminase elevation.
  • Inform patients of possible less serious but common adverse reactions of Veozah including abdominal pain, diarrhea, insomnia, back pain, and hot flush.
  • There are no data on the presence of fezolinetant in human milk, the effects on the breastfed child, or the effects on milk production. It is not known if fezolinetant is present in human milk.

What to do in case of emergency/overdose?[edit | edit source]

  • In case of overdose, call the poison control helpline of your country. In the United States, call 1-800-222-1222.
  • Overdose related information is also available online at poisonhelp.org/help.
  • In the event that the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services. In the United States, call 911.
  • Treatment of overdose consists of discontinuation of Veozah therapy with institution of appropriate symptomatic care.

Can this medicine be used in pregnancy?[edit | edit source]

  • There are no data on Veozah use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes.

Can this medicine be used in children?[edit | edit source]

  • The efficacy and safety of Veozah in individuals less than 18 years of age have not been established.

What are the active and inactive ingredients in this medicine?[edit | edit source]

  • Active ingredient: fezolinetant
  • Inactive ingredients: ferric oxide, hydroxypropyl cellulose, hypromellose, low-substituted hydroxypropyl cellulose, magnesium stearate, mannitol, microcrystalline cellulose, polyethylene glycol, talc, and titanium dioxide

Who manufactures and distributes this medicine?[edit | edit source]

Distributed by:

  • Veozah is a trademark of Astellas US LLC.

What should I know about storage and disposal of this medication?[edit | edit source]

  • Store Veozah at room temperature between 68°F to 77°F (20°C to 25°C).
  • Dispose of the unused medicine through a take-back option, if available.
Fezolinetant Resources

Find a healthcare provider anywhere in the world quickly and easily!

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski

WikiMD.png


WikiMD is the world's largest, free medical and wellness encyclopedia edited only by professionals. Advertise!

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Admin, Deepika vegiraju